Markt für pharmazeutische Arzneimittelverabreichung – Erkenntnisse aus globaler und regionaler Analyse – Prognose bis 2031

  • Report Code : TIPRE00007628
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 197
Buy Now

Der Markt für die Arzneimittelverabreichung wird im Jahr 2027 voraussichtlich 2.296.170,9 Mio. US-Dollar erreichen, gegenüber 1.403.082,9 Mio. US-Dollar im Jahr 2019. Der Markt wird im Zeitraum 2020–2027 voraussichtlich mit einer durchschnittlichen jährlichen Wachstumsrate von 6,6 % wachsen .



Arzneimittelverabreichungssysteme sind Technologien, die hauptsächlich für die kontrollierte oder gezielte Verabreichung verschiedener therapeutischer Wirkstoffe zur Behandlung verschiedener Krankheiten oder zur Verbesserung der Gesundheit der Patienten eingesetzt werden. Drug-Delivery-Systeme sind medizinische Geräte, mit denen Medikamente oder Chemikalien in den Körper injiziert werden. Zu den auf dem Markt erhältlichen Medikamentenverabreichungssystemen gehören transmukosale, orale, pulmonale, injizierbare, topische, nasale, implantierbare und okulare Systeme.



Lukrative regionale Märkte für die Arzneimittelabgabe



Markteinblicke



Wachsende Prävalenz infektiöser und chronischer Krankheiten



Die Prävalenz von Infektionskrankheiten, insbesondere bakteriellen Erkrankungen, nimmt weltweit kontinuierlich zu. Laut einer 2019 von der American Society for Microbiology veröffentlichten Studie werden weltweit jedes Jahr etwa 1,5 bis 4,5 Millionen Infektionen durch Carbapenem-resistente Enterobacteriaceae verursacht. Darüber hinaus führt diese Bakteriengruppe in den USA jedes Jahr zu Krankenhausaufenthalten von etwa 49.000 Menschen. Darüber hinaus verursachte Lungenentzündung laut einer von UNICEF veröffentlichten Studie im Jahr 2018 etwa 1.755.000 Todesfälle bei Kindern im Alter unter 5 Jahren. Außerdem kamen weltweit etwa 1.200.000 Kinder durch Durchfall ums Leben. Eine solche exponentiell wachsende Prävalenz von Infektionskrankheiten treibt den Konsum von Medikamenten voran, was letztendlich das Wachstum des Marktes für die Arzneimittelverabreichung vorantreibt.



Unter den chronischen Erkrankungen sind Krebs und Diabetes weltweit die häufigste Todesursache. Laut einer Studie der American Cancer Society (ACS) meldeten die USA beispielsweise im Jahr 2018 etwa 1.735.350 neue Krebsfälle. Darüber hinaus litten laut der International Diabetes Federation (IDF) im Jahr 2017 etwa 46 Millionen Amerikaner an Diabetes , und bis 2045 wird diese Zahl voraussichtlich 62 Millionen erreichen. Es wurde auch erwähnt, dass im Jahr 2017 weltweit etwa 425 Millionen Menschen mit Diabetes lebten und diese Zahl bis 2045 voraussichtlich 629 Millionen erreichen wird.





Einblicke in den Verabreichungsweg



Der Markt für die Arzneimittelverabreichung ist nach Verabreichungsweg in orale Arzneimittelverabreichung, injizierbare Arzneimittelverabreichung, topische Arzneimittelverabreichung und Augenmedikamente unterteilt Verabreichung, pulmonale Arzneimittelverabreichung, nasale Arzneimittelverabreichung, transmukosale Arzneimittelverabreichung und implantierbare Arzneimittelverabreichung. Das Segment der injizierbaren Arzneimittelverabreichung hielt 2019 den größten Marktanteil. Allerdings wird erwartet, dass das Segment der topischen Arzneimittelverabreichung im Prognosezeitraum die höchste CAGR auf dem Markt verzeichnen wird.



Markt für pharmazeutische Arzneimittelverabreichung, von Verabreichungsweg – 2019 und 2027



Einblicke in Anwendungen



Auf der Grundlage der Anwendungen wurde der Markt für die Arzneimittelverabreichung in Infektionskrankheiten, Krebs, Herz-Kreislauf-Erkrankungen, Diabetes und Atemwegserkrankungen segmentiert , Störungen des Zentralnervensystems, Autoimmunerkrankungen und andere Krankheiten. Das Krebssegment hatte 2019 den größten Marktanteil; Es wird jedoch geschätzt, dass das Segment Infektionskrankheiten im Prognosezeitraum die höchste CAGR verzeichnen wird.



Einblicke für Endbenutzer



Auf der Grundlage des Endbenutzers wurde der Markt für die Arzneimittelverabreichung segmentiert in Krankenhäuser, häusliche Pflegeeinrichtungen, ASC/Kliniken und andere Endbenutzer. Das Segment Krankenhäuser hielt 2019 den größten Marktanteil, während das Segment häusliche Pflege zwischen 2020 und 2027 schätzungsweise die höchste CAGR verzeichnen wird.



Strategische Einblicke



Produkteinführungen und Zulassungen sind eine gängige Strategie von Unternehmen, um ihre Präsenz weltweit auszubauen und der wachsenden Nachfrage gerecht zu werden. Diese Strategie wird am häufigsten von den Marktteilnehmern verfolgt, um ihre entsprechenden Produktportfolios zu erweitern.



Die auf dem Markt für die Arzneimittelverabreichung tätigen Akteure verfolgen die Strategie der Expansion, um den Kundenstamm auf der ganzen Welt zu vergrößern; Sie setzen auch die Strategien von Kooperationen und Produkteinführungen um. Diese Strategien ermöglichen es ihnen, ihren Markennamen weltweit zu behaupten. Beispielsweise erhielt GlaxoSmithKline plc im Mai 2018 eine FDA-Zulassung für die Verwendung von Arnuity Ellipta (Fluticasonfuroat) zur Erhaltungstherapie von Asthma bei Kindern unter 5 Jahren. Es handelt sich um ein einmal täglich inhaliertes Kortikosteroid (ICS)-Arzneimittel.



Über den Verabreichungsweg




  • Orale Arzneimittelverabreichung

  • Injizierbare Arzneimittelverabreichung
  • Topische Arzneimittelverabreichung

  • Okulare Arzneimittelverabreichung

  • Pulmonale Arzneimittelverabreichung

  • Nasale Arzneimittelverabreichung

  • Transmukosale Arzneimittelverabreichung
  • Implantierbare Arzneimittelabgabe


Durch Anwendung




  • Infektionskrankheiten

  • Krebs

  • Herz-Kreislauf-Erkrankungen< /li>
  • Diabetes

  • Atemwegserkrankungen

  • Störungen des zentralen Nervensystems

  • Autoimmunerkrankungen

  • Andere Anwendungen

  • < /ul>

    Nach Endbenutzer




    • Krankenhäuser

    • Einstellungen für die häusliche Pflege

    • ASC/Kliniken

    • Andere Endbenutzer


    Nach Geografie




    • Nordamerika

      • USA

      • Kanada

      • Mexiko


    • Europa

      • Deutschland

      • Großbritannien

      • Frankreich

      • Italien

      • < li>Spanien


    • Asien-Pazifik (APAC)

      • China

      • Indien

      • Japan

      • Südkorea

      • Australien



    • Naher Osten und Afrika (MEA)

      • Südafrika

      • Saudi-Arabien

      • VAE



    • Süd- und Mittelamerika (SCAM)

      • Brasilien

      • Argentinien



    Unternehmensprofile




    • Pfizer Inc.

    • Bayer AG

    • Johnson & Johnson Services, Inc.

    • Novartis AG

    • 3M

    • Becton, Dickinson and Company

    • Sanofi

    • Merck KGaA

    • GlaxoSmithKline plc.

    • Antares Pharma


Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What does pharmaceutical drug delivery mean?

Drug delivery systems are medical devices used to inject drugs or chemicals into the body. Some of the drug delivery systems available in the market include, transmucosal, oral, pulmonary, injectable, topical, nasal, implantable, and ocular among others. Drug delivery systems are the technologies primarily used for the controlled or targeted delivery of various therapeutic agents to treat various diseases or improve the health of the patients.

What are the driving and restraining factors for the pharmaceutical drug delivery market across the globe?

The growth of the market is attributed to some key driving factors such as growing prevalence of infectious and increasing r&d spending for drug delivery devices. However, high cost of drug delivery device development is likely to pose a negative impact on the market during the forecast years.

What is the regional analysis in terms of pharmaceutical drug delivery?

The North American region holds the largest market for the pharmaceutical drug delivery. The United States held the largest market for pharmaceutical drug delivery mean market and is expected to grow due to factors such as increasing incidence of cancer along with the growing need for diagnosing, demand for chronic disease medications from pharmaceutical companies, presence of key market players and extensive R&D conducted by various academic and research institutes.

The List of Companies - Pharmaceutical Drug Delivery Market

  1. Pfizer Inc.
  2. Bayer AG
  3. Johnson & Johnson Services, Inc.
  4. Novartis AG
  5. 3M
  6. Becton, Dickinson and Company
  7. Sanofi
  8. MERCK KGaA
  9. GlaxoSmithKline plc.
  10. Antares Pharma

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports